1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Upsurge in the Molecular Diagnosis 6.1.2 Increasing Incidences of Chronic Diseases and Aging Population 6.1.3 Increase in the Adoption of INAAT over PCR 6.1.4 Rise in the Miniaturization of Nucleic Acid Based Diagnosis 6.2 Market Restraints 6.2.1 Threatening Opposition from PCR Technologies 6.2.2 Lack of Awareness of New Diagnostics Technologies 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Technology 7.1.1 Helicase-dependent Amplification (HDA) 7.1.2 Nicking Enzyme Amplification Reaction (NEAR) 7.1.3 Loop-mediated Isothermal Amplification (LAMP) 7.1.4 Strand Displacement Amplification (SDA) 7.1.5 Nucleic Acid Sequence Based Amplification (NASBA) 7.1.6 Transcription Mediated Amplification (TMA) 7.1.7 Single Primer Isothermal Amplification (SPIA) 7.1.8 Others 7.2 By Applications 7.2.1 Oncology 7.2.2 Laboratory Research 7.2.3 Diagnostics 7.2.4 Blood Screening 7.2.5 Others 7.3 By Geography 7.3.1 North America 7.3.1.1 United States 7.3.1.2 Canada 7.3.1.3 Mexico 7.3.2 Europe 7.3.2.1 France 7.3.2.2 Germany 7.3.2.3 United Kingdom 7.3.2.4 Italy 7.3.2.5 Spain 7.3.2.6 Rest Of Europe 7.3.3 Asia-Pacific 7.3.3.1 China 7.3.3.2 Japan 7.3.3.3 India 7.3.3.4 Australia & New Zealand 7.3.3.5 South Korea 7.3.3.6 Rest of Asia-Pacific 7.3.4 Middle East & Africa 7.3.4.1 GCC 7.3.4.2 South Africa 7.3.4.3 Rest of the Middle East & Africa 7.3.5 South America 7.3.5.1 Brazil 7.3.5.2 Argentina 7.3.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Alere, Inc. 9.2 Becton, Dickinson & Company 9.3 BioHelix 9.4 bioMerieux 9.5 Hologica 9.6 New England Biolabs 9.7 Nugen 9.8 Qiagen 9.9 Quidel Corporation 9.10 List Not Exhaustive 10. Future of the Market

Alere, Becton, Dickinson & Company, Biomeriux, Hologica, Lucigen, Quidel Corporation, New England Biolabs, Nugen, Qiagen, Ustar Biotechnologies